251120.KQ Bio-FD&C Co. Ltd.

Healthcare Oil, Gas & Consumable Fuels KOSDAQ
9,140 KRW
Close of Oct 30, 2026
6,330 17,300
Market cap
KRW 78.0B
P/E
12.2x
P/B
1.07x
ROE
8.6%
Dividend yield
-
Fundamental score
2.1/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 251120.KQ undervalued?

Graham number
Price9,140
Graham value11,982
Discount23.7%

251120.KQ trades 23.7% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Bio-FD&C Co. Ltd. fundamental analysis

11 of 22 checks passed

ROE 0/2

Low return on equity (8.6%), below 10%.

ROA 1/1

Return on assets (8.2%) is above the industry median (1.4%).

Profit Consistency 2/2

Profitable for 8 consecutive years.

Earnings Growth 5Y 1/1

Earnings per share grew over the past 5 years.

Earnings Acceleration 1/1

Last year's EPS growth (48.1%) is above the 5-year average (22.5% a year).

Earnings Growth vs Industry 1/1

Last year's EPS growth (48.1%) is above the industry median (1.8%).

Revenue Growth 1/2

Revenue grew 6.5% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 0/2

Debt to equity cannot be calculated: debt is not reported or equity is negative.

Debt Trend 0/1

Debt to equity has risen over the past 5 years.

Debt Coverage 0/1

Debt is not reported.

Interest Coverage 1/1

EBIT is 397.4x against interest expense, well covered.

PE vs Market 0/1

PE (12.2x) is above the market median (11.3x).

PE vs Industry 0/1

PE (12.2x) is above the industry median (11.4x).

PBV 0/1

Price to book (1.1x) is above the industry median (0.9x).

Graham Number 1/1

The price is below the Graham number (PE x PB = 13.1, limit 22.5).

PEG 1/1

PEG on 5-year earnings growth is 0.54, growth is cheap.

Dividend Yield 0/2

No dividend paid in the last reported year.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

No dividend, or no profit to pay it from.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Bio-FD&C Co. Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Bio-FD&C Co. Ltd.

BIO-FD&C Co.,Ltd. develops active ingredients for anti-aging cosmetics in South Korea. It offers plant cell, peptide, natural extract, and biomolecule products for wrinkle improvement/skin regeneration, skin brightening, acne, skin irritation, wound healing, scalp improvement, skin moisturizing, fine dust, hair loss improvement, pores, lifting, whitening, skin texture, anti-inflammation/skin soothing, and anti-oxidation. The company was founded in 2005 and is headquartered i…

Full company profile